- 专利标题: HYDROGEL PRODRUG FOR TREATMENT
-
申请号: US18327658申请日: 2023-06-01
-
公开(公告)号: US20240123082A1公开(公告)日: 2024-04-18
- 发明人: Paul Fisher , Paulina Davis
- 申请人: Viking Scientific, Inc.
- 申请人地址: US CA San Marcos
- 专利权人: Viking Scientific, Inc.
- 当前专利权人: Viking Scientific, Inc.
- 当前专利权人地址: US CA San Marcos
- 主分类号: A61K47/69
- IPC分类号: A61K47/69 ; A61K9/00 ; A61K9/06 ; A61K9/14 ; A61K9/70 ; A61K31/195 ; A61K31/197 ; A61K31/198 ; A61K31/245 ; A61K31/522 ; A61K31/555 ; A61K31/606 ; A61K31/675 ; A61K31/704 ; A61K45/06 ; A61K47/08 ; A61K47/34 ; A61K47/55 ; A61K47/59 ; A61K47/60
摘要:
Aspects of the invention described herein include a hydrogel prodrug and methods of making a hydrogel prodrug for drug delivery. Also contemplated are methods of treating, inhibiting, ameliorating or inhibiting a disease or disorder. Without being limiting, the methods for treatment can be directed to a cancer, HIV, a virus, pain, a bacterial infection, a neurological disorder, hemorrhaging, multiple sclerosis, diabetes, high blood pressure, Alzheimer's, or inhibiting a fungal growth in a subject in need.
公开/授权文献
- US12083184B2 Hydrogel prodrug for treatment 公开/授权日:2024-09-10
信息查询